Immutep IMMP
NASDAQ IMMP
$3.32 +0.09 (+2.89%)
As of: Oct 21, 2026 · 1:16 PM EDT

Immutep (IMMP) Net Margin (2014 - 2017)

Updated

Immutep's Net Margin was -544.79% in the year ended Jun 30, 2026, up 49.85 percentage points from -594.64% a year earlier.

Analysis

Immutep (IMMP) Net Margin (2014 - 2017) Analysis & Trends

From the year ended Jun 30, 2009 onward, Immutep has reported Net Margin for 14 years.

  • Net Margin shows a four-year change of -544.77 percentage points (years ended Jun 2022 to Jun 2026).
  • The figure for the year ended Jun 30, 2026 marks the highest annual Net Margin since the year ended Jun 30, 2022.
  • Per Business Quant data, Net Margin in earlier years was -594.64% in the year ended Jun 30, 2025 and -0.02% in the year ended Jun 30, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,133.19 Bn 1,101.77 Bn 19.71 Bn 30.88%
2 Johnson & Johnson 616.03 Bn 534.56 Bn 17.26 Bn 21.86%
3 AbbVie 501.09 Bn 474.20 Bn 12.70 Bn 21.27%
4 Merck 366.82 Bn 321.20 Bn 12.21 Bn -8.04%
5 Novartis Ag 297.82 Bn 261.81 Bn 11.24 Bn 22.65%
6 Astrazeneca 261.33 Bn 235.02 Bn 12.86 Bn 16.30%
7 Amgen 235.89 Bn 191.29 Bn 7.24 Bn 23.62%
8 Gilead Sciences 190.64 Bn 164.84 Bn 6.22 Bn -134.51%
9 Pfizer 169.32 Bn 115.96 Bn 10.94 Bn -1.65%
10 Immutep 24.19 Mn -186.84 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 -366.03%
Mar 31, 2017 -129.02%
Jun 30, 2016 -1,468.42%
Mar 31, 2016 -687.45%
Jun 30, 2015 -19,101.30%
Jun 30, 2014 -83,767.85%
API Access

Immutep Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=IMMP&period=max&api_key=YOUR_API_KEY